Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum TELESTA THERAPEUTICS INC T.TST

"Telesta Therapeutics Inc is a biopharmaceutical company. The Company is engaged in the research, development, manufacturing and commercialization of human health products and technologies."

TSX:TST - Post Discussion

TELESTA THERAPEUTICS INC > Just a prediction
View:
Post by Jasl on Nov 14, 2015 10:50am

Just a prediction

I'm hoping for $1.39 high just before Adcomm just my thoughts. Anyone else have a thought on it. 
Cheers
JASL
Comment by Brouwie on Nov 14, 2015 11:07am
Which currency do you mean then ?
Comment by Jasl on Nov 14, 2015 11:28am
Canadian dollars
Comment by Brouwie on Nov 14, 2015 11:49am
hope you're right !!...But personally I think after the 18th (Adcomm) ..gl
Comment by DamnYankees on Nov 14, 2015 2:35pm
That is a 75% uptick Jasl! What makes you think Telesta will see an increase like that? my only thought is that sympathetic and or supportive panel will possibly drive speculation of a Yes vote when the membership is made public on Monday,While I think the submission will receive a yes on its own merit there is some smart money that might be prepared to increase the wager if the Adcomm roster ...more  
Comment by tater1 on Nov 14, 2015 3:25pm
 It seems like interest has peaked, this might be the price give or take a bit  that we will have until Thursday.   If nothing else a lower price helps to temper my temptation to sell a little before Adcom.   It has been my experience with this company that what I expecte to happen doesn't happen, so I am prepared for something  unexpected.   So the ...more  
Comment by DamnYankees on Nov 14, 2015 5:37pm
Will the make up of the Advomm panel be public on Monday morning or provided in confidence to the company? Anybody know. HT I know that you know
Comment by HighteawithIntrepid on Nov 14, 2015 7:20pm
The AdCom is actually a joint committee if you go to the FDA link you see a further link to the first part of the board. This is 12-13 names, then you have to use the search box and search for the Onocolgy board which is another 10-12 names by doing that you get the roughly 22 names that will be sitting on the 18th. and the voting numbers in April makes sense. Our best case scenario is to trade ...more  
Comment by DamnYankees on Nov 14, 2015 8:17pm
You are correct HT. It is the briefing material that is released Monday morning. Doubt that will tell bystanders too much
Comment by JPMUSSE on Nov 14, 2015 9:42pm
I have a gut feeling FDA is not approving this time again.
Comment by 1wascallywabbit on Nov 14, 2015 10:13pm
So did you get out of your position when it got back up to 0.85? Or u gonna be another long term bag-holder? LOL Sorry man. I feel for you, but I got in at 1.50 for a lot of it, then years later, had to go in over my head in the 20's and teens to get my average into the 30s.  I feel you will be ok, but you need to decide whether it is worth risking a few thousand or cut your loss here ...more  
Comment by DamnYankees on Nov 14, 2015 10:25pm
I'm not that good at math but I understand that 89.8% of applications that make it to this stage with the FDA are eventually approved. Of the 10.2% that are not approved 96% of those have lingering safety concerns that have to be re evaluated. So if we factor in fast track trial designation, priority review designation, app cost exemptions, 2nd line treatment status and current BC treatment ...more  
Comment by DryBones on Nov 15, 2015 2:22pm
Damn Yankee.  Based on your statistics it doesn't sound like a long shot, maybe a shot put. 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities